Candel Therapeutics, Inc. (CADL)
CADL Stock Price Chart
Explore Candel Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze CADL price movements and trends.
CADL Company Profile
Discover essential business fundamentals and corporate details for Candel Therapeutics, Inc. (CADL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
27 Jul 2021
Employees
38.00
Website
https://www.candeltx.comCEO
Paul-Peter Tak FOCIS,
Description
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. It also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. The company was incorporated in 2003 and is based in Needham, Massachusetts.
CADL Financial Timeline
Browse a chronological timeline of Candel Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 23 Mar 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$0.16.
Earnings released on 14 Aug 2025
EPS came in at -$0.09 surpassing the estimated -$0.17 by +47.06%.
Earnings released on 13 May 2025
EPS came in at $0.13 surpassing the estimated -$0.24 by +154.17%.
Earnings released on 13 Mar 2025
EPS came in at -$0.40 falling short of the estimated -$0.23 by -73.91%.
Earnings released on 14 Nov 2024
EPS came in at -$0.33 .
Earnings released on 13 Aug 2024
EPS came in at -$0.74 .
Earnings released on 14 May 2024
EPS came in at -$0.28 .
Earnings released on 28 Mar 2024
EPS came in at -$0.38 falling short of the estimated -$0.16 by -137.50%, while revenue for the quarter reached $1.78M .
Earnings released on 9 Nov 2023
EPS came in at -$0.29 falling short of the estimated -$0.19 by -52.63%.
Earnings released on 10 Aug 2023
EPS came in at -$0.33 falling short of the estimated -$0.23 by -43.48%.
Earnings released on 11 May 2023
EPS came in at -$0.30 surpassing the estimated -$0.35 by +14.29%.
Earnings released on 30 Mar 2023
EPS came in at -$0.18 falling short of the estimated -$0.16 by -12.50%, while revenue for the quarter reached $31.00K , beating expectations by +138.46%.
Earnings released on 10 Nov 2022
EPS came in at -$0.30 surpassing the estimated -$0.53 by +43.40%, while revenue for the quarter reached $31.00K , beating expectations by +100.00%.
Earnings released on 5 Aug 2022
EPS came in at -$0.14 surpassing the estimated -$0.54 by +74.07%, while revenue for the quarter reached $31.00K .
Earnings released on 12 May 2022
EPS came in at -$0.03 surpassing the estimated -$0.49 by +93.88%, while revenue for the quarter reached $31.00K , beating expectations by +50.00%.
Earnings released on 29 Mar 2022
EPS came in at $0.05 surpassing the estimated -$0.32 by +115.63%, while revenue for the quarter reached $31.00K , beating expectations by +106.67%.
Earnings released on 12 Nov 2021
EPS came in at -$0.34 falling short of the estimated -$0.27 by -25.93%, while revenue for the quarter reached $31.00K , beating expectations by +35.01%.
Earnings released on 8 Sept 2021
EPS came in at -$0.31 falling short of the estimated -$0.12 by -158.33%, while revenue for the quarter reached $31.00K .
Earnings released on 28 Jul 2021
EPS came in at -$0.24 , while revenue for the quarter reached $31.00K .
Earnings released on 31 Dec 2020
EPS came in at -$0.56 , while revenue for the quarter reached $31.00K .
Earnings released on 30 Sept 2020
EPS came in at -$0.14 , while revenue for the quarter reached $31.00K .
CADL Stock Performance
Access detailed CADL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.